Oncostatin M Signaling Pathway (Homo sapiens)

Jump to: navigation, search

As a member of the Interleukine (IL-6) cytotkine superfamily, Oncostatin M (OSM) besides, contributing to the normal physiology of repair, remodeling and hematopoiesis, also plays an important role in pathological conditions such as oncogenesis and inflammation (add ref). The activation of OSM receptors (LIFR and OSMR beta) by OSM, causes the formation of heterodimeric complex of LIFR-gp130 or OSMR-gp130 .

OSM mediated stimulation of its receptors, causes the activation of downstream signaling cascades. JAK/STAT, Ras/Raf/MAPK and PI 3-kinase through phosphorylation . On phosphorylation the STATs undergo homo- or hetero-dimerization, followed by their nuclear translocation and subsequent regulation of target gene expression . The dual effects of OSM, is mediated through the variation in phosphorylation of residues at selected sites, in different cell types or conditions. The OSM stimulation of JAK/STAT/PI 3 K leads to the increased expression of SOCS3 mRNA . The increased SOCS3 expression in turn effects the inactivation of JAK1, upon OSM stimulation.

1. Auguste, P., et al., Signaling of type II oncostatin M receptor. J Biol Chem, 1997. 272(25): p. 15760-4. 2. !!! INVALID CITATION !!! 3. Blanchard, F., et al., Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. J Biol Chem, 2001. 276(50): p. 47038-45. 4. Li, W.Q., F. Dehnade, and M. Zafarullah, Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol, 2001. 166(5): p. 3491-8. 5. Lin, S.K., et al., MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor. Arthritis Rheum, 2004. 50(3): p. 785-93. 6. Halfter, H., et al., Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells. Brain Res Mol Brain Res, 2000. 80(2): p. 198-206. 7. Hintzen, C., et al., Box 2 region of the oncostatin M receptor determines specificity for recruitment of Janus kinases and STAT5 activation. J Biol Chem, 2008. 283(28): p. 19465-77. 8. Ihn, H. and K. Tamaki, Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J Immunol, 2000. 165(4): p. 2149-55. 9. Mahboubi, K., et al., Desensitization of signaling by oncostatin M in human vascular cells involves cytoplasmic Tyr residue 759 in gp130 but is not mediated by either Src homology 2 domain-containing tyrosine phosphatase 2 or suppressor of cytokine signaling 3. J Biol Chem, 2003. 278(27): p. 25014-23.